Pontin silencing also reduced the levels of AKT protein in lung adenocarcinoma, which suggests that it may also function in the upstream activation of the pathway or can stabilize AKT as well (Figure 7C) (Yuan et al., 2016). Here, RUVBL1 is linked to lung adenocarcinoma.